tiprankstipranks
Trending News
More News >

Adaptimmune downgraded to Neutral from Outperform at Mizuho

Mizuho downgraded Adaptimmune (ADAP) to Neutral from Outperform with a 50c price target

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1